These results suggest that PNPLA3 genotype could be a useful tool to stratify the risk for HCC in the NAFLD population, of course, used in combination with other accepted risk factors. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.